RxSight
RXST
RXST
115 hedge funds and large institutions have $637M invested in RxSight in 2023 Q2 according to their latest regulatory filings, with 48 funds opening new positions, 45 increasing their positions, 13 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
55% more funds holding
Funds holding: 74 → 115 (+41)
18.17% more ownership
Funds ownership: 46.92% → 65.09% (+18%)
Holders
115
Holding in Top 10
1
Calls
$1.42M
Puts
$98K
Top Buyers
| 1 | +$41.8M | |
| 2 | +$31.5M | |
| 3 | +$15.8M | |
| 4 |
ACM
Atika Capital Management
New York
|
+$14.8M |
| 5 |
BlackRock
New York
|
+$11M |
Top Sellers
| 1 | -$20.1M | |
| 2 | -$16.4M | |
| 3 | -$1.76M | |
| 4 |
BM
Bridger Management
New York
|
-$1.65M |
| 5 |
MF
Magnetar Financial
Evanston,
Illinois
|
-$1.47M |